C_2021197EN.01000601.xml

Prior notification of a concentration

(Case M.10234 — Bain Capital/Cinven/Lonza Specialty Ingredients)

(Text with EEA relevance)

(2021/C 197/06)

On 11 May 2021, the Commission received notification of a proposed concentration pursuant to Article 4 of Council Regulation (EC) No 139/2004 (1).

This notification concerns the following undertakings:

—	Bain Capital Investors L.L.C. (‘Bain Capital’, US),

—	Cinven Capital Management (VII) General Partner Limited (‘Cinven’, UK),

—	The Lonza Specialty Ingredients business (‘Lonza Specialty Ingredients’, Switzerland), controlled by Lonza Group AG (Switzerland).

Bain Capital and Cinven acquire within the meaning of Article 3(1)(b) of the Merger Regulation joint control of the whole of Lonza Specialty Ingredients.

The concentration is accomplished by way of purchase of shares.

The business activities of the undertakings concerned are:

—	Bain Capital is a private equity investment firm that invests in companies across a number of industries, including information technology, healthcare, retail and consumer products, communications, financial services and industrial/manufacturing,

—	Cinven is a private equity business engaged in the provision of investment management and investment advisory services to a number of investment funds,

—

Lonza Specialty Ingredients provides microbial control solutions and chemical technologies for a range of end-uses including wood protection, oil and gas, plastics, metals, and paints and coatings applications. It also provides specialty products and services, such as composite materials, performance intermediates and chemicals, and custom development and manufacturing services for a range of applications and industries.

On preliminary examination, the Commission finds that the notified transaction could fall within the scope of the Merger Regulation. However, the final decision on this point is reserved.

The Commission invites interested third parties to submit their possible observations on the proposed operation to the Commission.

Observations must reach the Commission not later than 10 days following the date of this publication. The following reference should always be specified:

M.10234 — Bain Capital/Cinven/Lonza Specialty Ingredients

Observations can be sent to the Commission by email, by fax, or by post. Please use the contact details below:

Email:COMP-MERGER-REGISTRY@ec.europa.eu

Fax + 32 22964301

Postal address:

European Commission

Directorate-General for Competition

Merger Registry

1049 Bruxelles/Brussel

BELGIQUE/BELGIË

(1) OJ L 24, 29.1.2004, p. 1 (the ‘Merger Regulation’).